Table 3 |
|||
|
Independent risk factors for HCV seropositivity* |
|||
|
Variable |
Adjusted OR** |
95% Confidence Interval |
|
|
|
|||
|
Age |
|||
|
<30 ans |
1.00 |
||
|
≥ 30 ans |
3.44 |
1.46–8.12 |
|
|
Type of housing |
|||
|
Stable |
1.00 |
||
|
Precarious |
1.80 |
0.99–3.27 |
|
|
HIV serology |
|||
|
Negative |
1.00 |
||
|
Positive |
29.17 |
9.79–86.87 |
|
|
Injected at least once |
|||
|
No |
1.00 |
||
|
Yes |
9.25 |
4.02–21.27 |
|
|
Crack smoking (last month) |
|||
|
No |
1.00 |
||
|
Yes |
2.65 |
1.19–5.91 |
|
|
Substitution therapy |
|||
|
No |
1.00 |
||
|
Yes |
3.24 |
1.01–10.37 |
|
|
|
|||
|
* Multiple logistic regression analysis among French DUs. ANRS-Coquelicot study, France, 2004–2005 (N = 794) **The reported prevalence odds ratios were adjusted for all the characteristics included in the table. |
|||
|
Jauffret-Roustide et al. BMC Infectious Diseases 2009 9:113 doi:10.1186/1471-2334-9-113 |
|||
